Drug or treatment

Zinlirvimab clinical trials

• 2Clinical trials
• 3Countries

All recruiting trials (2)

• Long-acting LEN/TAB/ZAB regimen vs daily HIV meds in adults with suppressed HIV-1

  This study tests whether switching to an injectable, long-acting combination (lenacapavir, teropavimab, zinlirvimab) can keep HIV-1 under control in adults who are already virally suppressed on stable oral therapy.

  Recruiting at 2 sites Phase 3 Gilead Sciences · Berkeley, Michigan and 1 other locations · NCT07683000

• Long-acting LEN/TAB/ZAB vs CAB/RPV in adults with HIV-1 who are virologically suppressed on daily ART

  This study tests whether switching to a weekly-plus long-acting injectable regimen of lenacapavir, teropavimab, and zinlirvimab works as well as a two-drug injectable regimen of cabotegravir and rilpivirine for adults with HIV-1 who already have undetectable virus on daily treatment.

  Recruiting at 19 sites Phase 3 Gilead Sciences · San Francisco, California and 18 other locations · NCT07682961

Quick answers

How many clinical trials of Zinlirvimab are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (2 trials), Australia (1 trial), Japan (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →